Private 1:1 Psilocybin Mushroom Meditation

Once applications are accepted and dates arranged, the preparation phase includes the presentation of introductory educational content, baseline psychometric measurements that will be used to help evaluate the impact of the session, and the option to schedule one or more sessions with our allied psychologists, who specialise in the preparation and integration for psychedelic experiences. While these sessions are not mandatory, we do strongly encourage candidates to take the opportunity, particularly those who are approaching psychedelics from a state of significant mental distress, such as depression, anxiety, OCD or addiction. People in such states are precisely those who are most likely to encounter the most challenges during a session, and expertly guided preparation from an experienced clinician can significantly improve both the immediate experience of the session as well as the long-term outcomes. We consider it an ethical responsibility to refer candidates to appropriately qualified specialists when presented with necessities beyond the scope of our expertise.

The session begins with a preparatory discussion, during which we set and record intentions, work through doubts and fears, advise how to respond to challenging experiences, and quieten the mind with a "mindful eating" meditation. The mushrooms are served in a tea ceremony including an infusion of herbal extracts shown in several clinical trials to reduce anxiety significantly in patients awaiting surgery. This is particularly apt as a high dose psychedelic session is comparable to performing a deep surgical operation on your own mind.

Some days after the session, we provide the opportunity to record outcome measurements and send a personal aftercare email with suggestions on how to continue the journey. We collaborate with several research organisations whose studies we refer individuals who participate in our sessions to join, such as Quantified Citizen and Psychedelic Survey, collaborative platforms enriching today's psychedelic renaissance through stronger knowledge sharing, giving people around the world the ability to help psychedelic science by sharing their own meaningful experiences anonymously. On such platforms we invite our participants to join studies such as the Understanding Experiences with Psychedelics study led by the University of Michigan, whose newly established Psychedelic Centre is already publishing some fascinating research. Since we include an introduction to microdosing and meditation in the post-session integration aftercare, we also invite our participants to join the Microdose study led by Zachary Walsh of the University of British Columbia, as well as the Meditation and Microdosing study, designed by Marco Schlosser at University College London and co-run by Amanda Feilding at the Beckley Foundation, Carla Pallavicini and Enzo Tagliazucchi at the University of Buenos Aires, and Otto Simonsson at the Karolinska Institute.